These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 26208896)

  • 1. Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.
    Nguyen T; Duan Z; Naik AD; Kramer JR; El-Serag HB
    Gastroenterology; 2015 Nov; 149(6):1392-8. PubMed ID: 26208896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use is associated with a decreased risk of Barrett's esophagus.
    Nguyen T; Khalaf N; Ramsey D; El-Serag HB
    Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
    Nguyen DM; Richardson P; El-Serag HB
    Gastroenterology; 2010 Jun; 138(7):2260-6. PubMed ID: 20188100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
    Beales IL; Vardi I; Dearman L; Broughton T
    Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma.
    Beales IL; Vardi I; Dearman L
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):917-23. PubMed ID: 22569083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
    Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus.
    Nguyen T; Thrift AP; Yu X; Duan Z; El-Serag HB
    Am J Gastroenterol; 2017 Jul; 112(7):1049-1055. PubMed ID: 28244499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER-Medicare Analysis.
    Loomans-Kropp HA; Chaloux M; Richmond E; Umar A
    Cancer Prev Res (Phila); 2021 Feb; 14(2):195-204. PubMed ID: 32998939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.
    Nguyen DM; Schwartz J; Richardson P; El-Serag HB
    Dig Dis Sci; 2010 Dec; 55(12):3404-7. PubMed ID: 20397052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin use is associated with reduced risk of histologic subtypes of esophageal cancer: a nested case-control analysis.
    Alexandre L; Clark AB; Bhutta HY; Holt S; Lewis MP; Hart AR
    Gastroenterology; 2014 Mar; 146(3):661-8. PubMed ID: 24315828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma.
    Thomas T; Loke Y; Beales ILP
    J Gastrointest Cancer; 2018 Dec; 49(4):442-454. PubMed ID: 28691139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.
    Beales IL; Dearman L; Vardi I; Loke Y
    Dig Dis Sci; 2016 Jan; 61(1):238-46. PubMed ID: 26386857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between statins and cancer incidence in a veterans population.
    Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
    J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.
    Choi SE; Perzan KE; Tramontano AC; Kong CY; Hur C
    Cancer Prev Res (Phila); 2014 Mar; 7(3):341-50. PubMed ID: 24380852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
    Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
    Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.